ATE131071T1 - Leukozyten-adhäsions-inhibitor. - Google Patents
Leukozyten-adhäsions-inhibitor.Info
- Publication number
- ATE131071T1 ATE131071T1 AT89910339T AT89910339T ATE131071T1 AT E131071 T1 ATE131071 T1 AT E131071T1 AT 89910339 T AT89910339 T AT 89910339T AT 89910339 T AT89910339 T AT 89910339T AT E131071 T1 ATE131071 T1 AT E131071T1
- Authority
- AT
- Austria
- Prior art keywords
- leukocyte adhesion
- adhesion inhibitor
- endothelial cells
- endothelial
- inflammation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5421—IL-8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Rheumatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- General Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23222488A | 1988-08-15 | 1988-08-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE131071T1 true ATE131071T1 (de) | 1995-12-15 |
Family
ID=22872317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT89910339T ATE131071T1 (de) | 1988-08-15 | 1989-08-15 | Leukozyten-adhäsions-inhibitor. |
Country Status (6)
Country | Link |
---|---|
US (1) | US5302384A (de) |
EP (1) | EP0429542B1 (de) |
JP (1) | JPH04500076A (de) |
AT (1) | ATE131071T1 (de) |
DE (1) | DE68925032T2 (de) |
WO (1) | WO1990001338A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2223225B (en) | 1987-11-19 | 1992-07-08 | Sandoz Ltd | Neutrophil-activating factor: its production and use in treatment |
WO1991008231A1 (en) * | 1989-11-29 | 1991-06-13 | Brigham And Women's Hospital | [Ala IL-8]77 AS A LEUKOCYTE ADHESION INHIBITOR |
AU6747190A (en) * | 1989-11-29 | 1991-06-26 | Brigham And Women's Hospital | Endothelial-derived il-8 |
EP0616615B1 (de) * | 1991-12-04 | 1998-08-12 | The Biomedical Research Centre Limited | Analoge des menschlichen Interleukin-8. |
US7135458B1 (en) * | 1995-11-15 | 2006-11-14 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use |
US5811073A (en) * | 1995-06-19 | 1998-09-22 | President And Fellows Of Harvard College | Method for radioisotopic detection and localization of inflammation in a host |
DE19548630A1 (de) * | 1995-12-12 | 1997-06-19 | Schering Ag | Verfahren zur Reinigung von rekombinantem Human-Interleukin - 8 |
US6989435B2 (en) | 1997-09-11 | 2006-01-24 | Cambridge University Technical Services Ltd. | Compounds and methods to inhibit or augment an inflammatory response |
US7067117B1 (en) | 1997-09-11 | 2006-06-27 | Cambridge University Technical Services, Ltd. | Compounds and methods to inhibit or augment an inflammatory response |
US7238711B1 (en) | 1999-03-17 | 2007-07-03 | Cambridge University Technical Services Ltd. | Compounds and methods to inhibit or augment an inflammatory response |
DE10003811A1 (de) * | 2000-01-28 | 2001-08-09 | Sanorell Pharma Gmbh & Co | Verfahren zur Herstellung eines serumhaltigen Kulturmediums für Zellen sowie dessen Verwendung |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5729949A (en) * | 1980-07-30 | 1982-02-18 | Nippon Koutai Kenkyusho:Kk | Determination of sugar branch related to cancer and diagnostic technique of cancer |
US4897348A (en) * | 1983-08-25 | 1990-01-30 | Sri International | Recombinant materials and methods for producing human connective tissue-activating peptide-III and analogs thereof |
ES2080044T3 (es) * | 1987-05-04 | 1996-02-01 | Dana Farber Cancer Inst Inc | Moleculas de adhesion intercelular y sus ligandos de fijacion. |
US4840793A (en) * | 1987-06-11 | 1989-06-20 | Dana-Farber Cancer Institute | Method of reducing tissue damage at an inflammatory site using a monoclonal antibody |
US4797277A (en) * | 1987-09-22 | 1989-01-10 | Pharmacia Ab | Method for reperfusion therapy |
GB2223225B (en) * | 1987-11-19 | 1992-07-08 | Sandoz Ltd | Neutrophil-activating factor: its production and use in treatment |
-
1989
- 1989-08-15 EP EP89910339A patent/EP0429542B1/de not_active Expired - Lifetime
- 1989-08-15 DE DE68925032T patent/DE68925032T2/de not_active Expired - Fee Related
- 1989-08-15 WO PCT/US1989/003479 patent/WO1990001338A1/en active IP Right Grant
- 1989-08-15 AT AT89910339T patent/ATE131071T1/de not_active IP Right Cessation
- 1989-08-15 JP JP1509680A patent/JPH04500076A/ja active Pending
-
1993
- 1993-02-25 US US08/028,705 patent/US5302384A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE68925032T2 (de) | 1996-04-25 |
JPH04500076A (ja) | 1992-01-09 |
EP0429542B1 (de) | 1995-12-06 |
EP0429542A4 (en) | 1991-12-11 |
DE68925032D1 (de) | 1996-01-18 |
US5302384A (en) | 1994-04-12 |
WO1990001338A1 (en) | 1990-02-22 |
EP0429542A1 (de) | 1991-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE131071T1 (de) | Leukozyten-adhäsions-inhibitor. | |
DE69517196D1 (de) | Inhibitoren der menschlichen neutrophilenelastase | |
DE69027990T2 (de) | Kultur des wachstumsfaktors der vaskularen endothelialzellen und dns, die dafür kodiert | |
ATE12502T1 (de) | Phosphinylalkanoyl-substituierte proline. | |
DE69818049D1 (de) | Inhibitoren der alpha4-beta1 vermittelten zelladhäsion | |
MY104685A (en) | Substituted thiazoles and their use as fungicides. | |
DK0489837T3 (da) | Inhibering af lymfocytters adhæsion til vaskulært endotel under anvendelse af en hidtil ukendt interaktion mellem ekstracellulær matrixreceptor og ligand | |
WO1992015605A3 (en) | Inhibitors of human neutrophil elastase and human cathepsin g | |
DK0402068T3 (da) | Polypeptider og polypeptidanaloger med inhiberende virkning mod human elastase | |
ES2136091T3 (es) | Inhibidores de catepsina g y elastasa para prevenir la degradacion del tejido conectivo. | |
FR2643557B1 (fr) | Utilisation de n-acylcysteines dans le traitement de maladies associees aux infections par hiv | |
DK0782441T3 (da) | Farmaceutisk kontrol af inflammation | |
DK0830130T3 (da) | TNF-alfa-omdannende enzym | |
FI935780A (fi) | HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten | |
FI943357A (fi) | Puheen lomitussyvyyden suurentaminen yhdessä lyhennetyn viiveen kanssa | |
ES2168095T3 (es) | Inhibidores de neutrofilos procedentes de nematodos. | |
ATE182890T1 (de) | 3-alkyloxy-, aryloxy-, oder arylalkyloxy- benzo(b>thiophen- 2-carboxamide als inhibitoren von zelladhäsion | |
DE69021128T2 (de) | Interleukin-1-Inhibitor. | |
BG102404A (en) | The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system | |
DK0862454T3 (da) | CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner | |
ATE233570T1 (de) | Verwendung des leukämie-inhibitor-faktor und endothelin antagonisten | |
PL307864A1 (en) | Retroviral infection inhibition | |
FR2698270B1 (fr) | Utilisation du 5-méthoxypsoralène dans le traitement du sida. | |
DE69227089T2 (de) | Weizen Alpha-Amylase-Inhibitor zur Behandlung von Diabetes | |
FI982503A0 (fi) | C3-C3-polyfluorialkaanien käyttö ponnekaasuina suihkuttimissa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |